EP1109899A1 - Produkt und methode zur auftrennung einer probe enthaltend genetisches material aus multipeln quellen mittels eines festen mediums - Google Patents
Produkt und methode zur auftrennung einer probe enthaltend genetisches material aus multipeln quellen mittels eines festen mediumsInfo
- Publication number
- EP1109899A1 EP1109899A1 EP99945766A EP99945766A EP1109899A1 EP 1109899 A1 EP1109899 A1 EP 1109899A1 EP 99945766 A EP99945766 A EP 99945766A EP 99945766 A EP99945766 A EP 99945766A EP 1109899 A1 EP1109899 A1 EP 1109899A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- genetic material
- solid medium
- sample
- solution
- plasmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
Definitions
- the present invention is directed to the storage, separation and analysis of genetic material.
- the invention is particularly suited for separating a genetic material from a sample containing multiple sources of a genetic material using a solid medium.
- Crude samples having multiple sources of genetic material include, for example, blood, feces, tissue fluids, plasmid containing bacteria, etc.
- the use of bacteria for propagation of plasmids is common in the study of genomics, analytic molecular biology, preparation molecular biology, etc. Methods for propagating plasmid containing bacteria are known.
- Common methods for storage of bacteria containing plasmids prior to analysis of the genetic material of the plasmid include, for example, filter paper, plastic, ceramic, semi-conductor, metal, etc.
- the present invention is directed products and methods for purifying or separating a genetic material from a crude sample applied to a solid medium.
- the invention provides for separating a selected genetic material from a sample containing genetic material from multiple sources. It will be appreciated that throughout the specification, guidance may be provided through lists of examples. In each instance, the recited lists serve only as a representative group. It is not meant, however, that the lists are exclusive.
- a sample of genetic material can be stored on a solid medium as described below.
- non-genetic material typically associated with a crude sample for example, proteins, fats, etc.
- the dry solid medium can then be rinsed using a rinsing solution and the genetic sample analyzed in situ.
- the genetic material can be eluted from the solid medium and analyzed away from the solid medium.
- the invention further provides for purifying and removing a selected genetic material from a sample including genetic material, optionally including genetic material from more than one source.
- the genetic material remaining on the solid medium can be further analyzed in situ, or, alternatively, the genetic material removed from the solid medium can further be analyzed away from the solid medium.
- the present invention is directed to products and methods which provide for separating genetic material derived from a crude sample that may contain genetic material from more than one source.
- the term “genetic material” includes a nucleotide sequence comprising two or more nucleotide bases including, for example, DNA, RNA, cDNA, oligonucleotides, entire genes, partial genes, entire genomes, etc.
- a “crude sample” refers to a sample of genetic material including components typically associated with the genetic material in vivo (e.g., proteins, fats, etc.) and includes, for example, a buccal swab, blood, serum, plasma, semen, feces, urine, cerebral spinal fluid, synovial fluid lymphatic fluid, etc.
- a “crude sample” also includes bacterial cultures, viral suspensions, etc.
- a "source” from which the genetic material is derived includes, for example, any type of eukaryotic or prokaryotic cell, viruses, plasmids, phages, archeobacteriae, plastids, cosmids, viroids, tissue fluids (blood, cerebrospinal fluid, lymphatic fluid, saliva, urine, etc.), etc.
- the products and methods of the invention are particularly suited for purifying plasmid genetic material and separating genetic material of plasmids from bacteria containing the plasmids.
- a sample containing genetic material can be applied to and stored on a medium comprising a support matrix such as paper (cellulose, nitrocellulose, etc.), plastic, ceramic, semi-conductor, metal, or other porous material or micro-indented surface or surface equipped with micropoles or microtrabeculae.
- a support matrix such as paper (cellulose, nitrocellulose, etc.), plastic, ceramic, semi-conductor, metal, or other porous material or micro-indented surface or surface equipped with micropoles or microtrabeculae.
- the methods of the invention may also be used on genetic samples applied to and stored on a semi-solid matrix such as agar gel, agarose gel, polyacrylamide gel, etc.
- the storage medium may also include one or more components which protect the stored genetic material from damage or degradation, denature proteins or which are useful for analysis of the stored genetic material. Examples of some such matrices are disclosed in U.S. Patent Nos. 5,939,259; 5,807,527; 5,756,126; and 5,496,562; and co-pending U.S. Serial No. 08/574,888.
- analysis of the genetic material includes methods used in the art for analyzing DNA or RNA such as sequencing, amplifying, hybridizing, probing, endonuclease restriction, ligation cloning, preparation for mass spectroscopy or irradiation, or any other procedure that is performed to obtain information about the genetic material.
- the genetic material can be analyzed immediately after taking the sample or stored for analysis at a later time.
- some or all of the analysis to be performed on a particular source of genetic material can be analyzed in situ (i.e., on the medium) while source(s) not to be analyzed are removed from the medium prior to analysis.
- the genetic material to be analyzed can be removed from the medium, for example, the sources of genetic material which are not to be analyzed can remain on the medium and the genetic material to be analyzed removed from the medium prior to analysis.
- the methods herein described provide for selective removal from the solid medium of either the genetic material to be analyzed or the genetic material (and/or associated non-genetic material) not being analyzed.
- a sample of genetic material can include the genetic material of a bacterium (e.g., DNA and/or RNA) and the genetic material of a plasmid (e.g., DNA) that is contained within the bacteria.
- a wet sample of the bacteria containing the plasmid can be applied to the medium and permitted to dry. After drying, and typically prior to analysis of the genetic material, the genetic material of the bacteria and plasmid are separated.
- Either the bacterial genetic material or the plasmid genetic material can be removed from the medium and the genetic material remaining on the medium analyzed in situ and/or the genetic material removed from the medium analyzed away from the medium.
- the plasmid genetic material can be removed from the medium and the bacterial genetic material left on the medium. If it is desired to analyze the genetic material of the plasmid, the plasmid can be eluted into an eluting solution from which further analysis of the plasmid genetic material can be performed. Alternatively, if it is desired to analyze the genetic material of the bacteria, once the plasmid genetic material is removed from the medium, the bacterial genetic material can be analyzed in situ on the medium.
- a cleaning solution can be applied to remove components of the crude sample which are present on the medium and which can interfere with, or are not necessary for, analysis of the genetic material.
- the cleaning solution can be followed by a rinsing solution.
- an eluting solution can be applied to remove the genetic material of the source(s) selected to be removed without substantially removing the genetic material selected to remain on the medium.
- Non-genetic material includes sample constituents such as proteins, fats, cellular debris, bacterial techoic acids, plant tannins, other secondary plant products or components of the medium such as protein denaturing agents (e.g.. detergents; urea; guanidium salts, such as guanidine thiocyanate, guanidine isothiocyanate, guanidine hydrochloride; sodium iodide; chelating agents such as EDTA; free radical traps such as uric acid or a urate salt, guanidine thiocyanate, etc.; protective agents; etc.
- the cleaning solution can also provide for RNA removal, for example, by selective RNA destruction in alkaline solution.
- the cleaning solution can be a "partial aqueous, alkaline solution” (PAA).
- PAA partial aqueous, alkaline solution
- a “PAA” solution includes a water miscible solvent (e.g., alcohol, methanol, ethanol, propanol, butanol, their isometric diols or polyols, etc.; acetone, etc.) in combination with a source of high pH.
- concentrations of ethanol can be about 30 to 90%, typically about 45% to 70%.
- a "high pH” source provides a PAA solution pH of about 9.0 to 13, preferably about 11.
- sources of high pH include: NaOH , KOH, LiOH, quaternary nitrogen base hydroxide, tertiary, secondary or primary amines, etc.
- a preferred PAA can function as a denaturing agent as well as a solvent for solubilizing and removing protein from the medium.
- detergent or chaotropic alcohol solutions for example, an anionic detergent in combination with an alcohol can also be used as a cleaning solution.
- additional less preferred cleaning solutions include, for example, certain chaotropic agents in alcohol and phenol solutions. Suitable phenol solutions are disclosed in U.S. Patent No. 5,756,126 and co-pending Serial No. 08/574,888, the entire disclosures of which are incorporated herein by reference.
- complementary cross linking and relative size of the bacterial DNA facilitates retention to the solid medium.
- covalently attaching DNA sequences or peptide NA (PNA) sequences to the medium can be utilized to enhance the differential binding of one source of genetic material over another.
- enhanced binding of one type of genetic material versus another can be provided by incorporating some reverse-phase characteristics to the medium.
- Such reverse-phase characteristics can be provided, for example, by slightly siliconizing a hydrophobic medium or attaching benzyl, napthyl or similar groups.
- a "rinsing solution” provides for removing non-genetic material remaining after removal of the cleaning solution as well as removing or neutralizing components of the cleaning solution.
- a rinsing solution can comprise the water miscible solvent of the cleaning solution.
- this includes alcohols such as methanol, ethanol, propanol, butanol, their isometric diols or polyols, etc.; acetone, etc.
- the rinsing solution can either be unbuffered or contain a buffer at neutral pH or slightly below pH 7.0. When present, a buffer aids in the neutralization of the alkali of the cleaning solution.
- the composition of the buffer is selected so that traces of the buffer that are carried through the preparation procedure are compatible with the subsequent application of the genetic material.
- Tris and EDTA buffers are suitable if the final usage of the DNA is to be as a solution in EDTA containing buffers.
- one preferred buffer for general usage is ammonium acetate at concentrations between 5 mM and 100 mM, with or without a small amount of EDTA, for example, 0.1 mM. EDTA.
- an “eluting solution” is a solution that selectively removes the genetic material of one or more sources from the medium without substantially removing other sources.
- substantially means that while the separation of the source(s) of genetic material selected to be removed and the source(s) selected to remain may not be perfect, the separation is sufficient to provide reliable analytic results of the genetic material to be analyzed.
- the eluting solution is a saline eluting solution.
- saline eluting solutions include ethylenediaminetetraacetic acid (EDTA), sodium citrate, acetate, Tris EDTA buffer (TE), ammonium acetate (e.g., 10 mM concentration), carbonate salts, bicarbonates (e.g., 10 mM concentration), etc.
- Tris EDTA buffer can be prepared by combining 10 mM Tris free base and 1 mM EDTA, and adjusting to pH 8 with HC1.
- the eluting solution can also contain ethanol acetone, methanol, propanol, butanol, etc. and their isomeric diols and polyols.
- the foregoing components can be present in lower levels than contained in the cleaning and/or rinsing solution, for example, 0%> to 55%> v/v.
- the preferred concentration of these components for non-selective extraction is, however, 0%.
- the genetic material to be eluted from the medium can be eluted using such methods as centrifugation, vacuum, diffusion, electrophoresis and electro-osmosis.
- the method of this Example is advantageous for use when a small amount of plasmids are needed from large numbers of samples as, for example, when sequencing large numbers of plasmids. According to this Example, handling is minimized while time consumed by the procedure may be increased. All operations were at room temperature, (i.e., about 20° C)
- E. coli Escherichia coli
- DH10B Escherichia coli
- pBC-SR plasmids 1 ml cultures of Escherichia coli (E. coli) strain DH10B containing pBC-SR plasmids were centrifuged for 5 minutes at 150,000 rpm. Each centrifuged pellet was taken up in 10 :1 of water with a trace of bromophenol blue as an indicator of position, and then deposited on a piece of FTA® paper (available from Fitzco, Inc., Plymouth, MN) as a blue spot, allowed to dry and stored dry.
- FTA® paper available from Fitzco, Inc., Plymouth, MN
- the cleaning solution was aspirated and a rinsing solution of 1.0 ml, 95% ethanol was added and agitated gently for 5 minutes at room temperature and then dried.
- An eluting solution of 15 :1 of 5 mM tris EDTA at pH 8.3 was applied to the disc and left overnight at 4°C for the plasmid to elute.
- the eluting solution and eluant were removed from the tube.
- the product was electrophoresed on 1% agarose gel and visualized with ethidium bromide by standard technology. Faint but clear plasmid bands were observed with the expected mobility and with a brightness indicative of a satisfactory yield for the very small amount of starting material.
- This Example is advantageous for use when larger amounts of plasmid are needed, as for example when restriction mapping is to be performed.
- This Example uses centrifugal stripping to remove solutions from the paper instead of long periods of diffusion. Centrifugal stripping was at 2500 rpm and each stripping took an additional 5 minutes for the centrifugation. All operations were at room temperature (20° C).
- One spot of plasmid-containing E. coli that had been held for 6 days on FTA® paper as described in Example 1 was cut into 4 sections and one of the four sections, of approximately 4 mm square, was placed in an apparatus suitable for centrifugal stripping (e.g., a test tube with a hole in the bottom, inside another tube that collects the eluate) and the centrifugal eluates collected.
- an apparatus suitable for centrifugal stripping e.g., a test tube with a hole in the bottom, inside another tube that collects the eluate
- Other suitable systems for stripping will be apparent to those skilled in the art.
- 150 :1 of cleaning solution was applied 4 times at about 2.5 minutes per time.
- the cleaning solution comprised 62% alcohol and the remainder being water with an overall composition for the water plus alcohol of 0.1 M NaOH.
- the section was rinsed two times for about 2 minutes each time using 150 :1 of 95%o alcohol water.
- the elapsed time of washing and rinsing, inclusive of centrifugation time, is approximately 1 hour.
- An eluting solution of 15 :1 TE buffer was applied 1 minute followed by centrifugation.
- the present Example describes purification of a sample of blood DNA stored on a solid medium and subsequent removal of the DNA from the solid medium.
- a 6 mm disc of dry blood (approximately 16 ⁇ l) was previously applied to FTA® paper available from Fitzco, Inc., Madison, MN.
- the sample was washed two times with a cleaning solution of 1.0 ml of 0.3 M NaCO 3 at room temperature. The first wash was for 30 minutes followed by aspiration and the second wash for 20 minutes followed by aspiration and spinning. The sample was then washed with 50 mM acetic acid for approximately 2 minutes followed by spin stripping and heating dry for 10 minutes at 99°. Subsequently, 20 ⁇ l of 15 Mm NaCO 3 was applied to the sample at 99 °C for 2-2.5 minutes and then eluted with 2 aliquots of 50 ⁇ l of water. The eluant was frozen in 10 ⁇ l lots and subsequently analyzed successfully by polymerase chain reaction (PCR).
- PCR polymerase chain reaction
- a 6 mm disc was punched out of a blood sample stored on FTA® paper.
- the non-genetic material particularly proteins and components of the FTA® paper
- the first wash was 25 minutes (long enough to imbibe the blood).
- the second wash was for 10 minutes and the sample was subsequently centrifugally stripped.
- the cleaning solution was removed by washing and spin stripping with 3 aliquots of 200 ⁇ l each of water. The sample was exposed to the water for 1 to 2 minutes between each washing. The blood color of the disc was substantially gone at this point.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9971598P | 1998-09-10 | 1998-09-10 | |
US99715P | 1998-09-10 | ||
PCT/AU1999/000753 WO2000015776A1 (en) | 1998-09-10 | 1999-09-10 | Product and method for separation of a sample containing multiple sources of genetic material using a solid medium |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1109899A1 true EP1109899A1 (de) | 2001-06-27 |
EP1109899A4 EP1109899A4 (de) | 2003-07-02 |
EP1109899B1 EP1109899B1 (de) | 2007-02-21 |
Family
ID=22276286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99945766A Expired - Lifetime EP1109899B1 (de) | 1998-09-10 | 1999-09-10 | Produkt und methode zur auftrennung einer probe enthaltend genetisches material aus multipeln quellen mittels eines festen mediums |
Country Status (8)
Country | Link |
---|---|
US (1) | US6291179B1 (de) |
EP (1) | EP1109899B1 (de) |
AT (1) | ATE354651T1 (de) |
AU (1) | AU764494B2 (de) |
CA (1) | CA2350315C (de) |
DE (1) | DE69935232T2 (de) |
ES (1) | ES2281971T3 (de) |
WO (1) | WO2000015776A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018206772A1 (de) | 2017-05-11 | 2018-11-15 | Immundiagnostik Ag | Verfahren und testbesteck zur quantitativen bestimmung von biomarkern in fäkalproben |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050032061A1 (en) * | 2001-11-05 | 2005-02-10 | Riken | Method of storing and/or delivering an oligomer and/or polymer applied on a support, and supports thereof |
US20040151637A1 (en) * | 2003-01-30 | 2004-08-05 | Davin Bradley Ferguson | Slide mount collection or storage device for biological specimen |
US20040265187A1 (en) * | 2003-01-30 | 2004-12-30 | Davin Bradley Ferguson | Blood collection slide |
WO2005007852A2 (en) * | 2003-07-09 | 2005-01-27 | Genvault Corporation | Room temperature elution of nucleic acids |
US7320891B2 (en) * | 2004-09-10 | 2008-01-22 | Promega Corporation | Methods and kits for isolating sperm cells |
JP2010505425A (ja) * | 2006-10-06 | 2010-02-25 | プロメガ コーポレイション | 細胞を単離する方法およびキット |
US20130122496A1 (en) * | 2011-09-30 | 2013-05-16 | Blood Cell Storage, Inc. | Storage of nucleic acid |
GB201603459D0 (en) * | 2016-02-29 | 2016-04-13 | Ge Healthcare Uk Ltd | Solid support for sample collection |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3872082A (en) * | 1971-05-19 | 1975-03-18 | Boehringer Mannheim Gmbh | Substituted purineribofuranoside-3,5-cyclophosphate compounds and process for their preparation |
US4533628A (en) * | 1983-08-03 | 1985-08-06 | New York University | Colony hybridization method |
WO1989000577A1 (en) * | 1987-07-22 | 1989-01-26 | Imperial Cancer Research Technology Ltd. | Digestion method |
WO1996018731A2 (en) * | 1994-12-12 | 1996-06-20 | Dynal A/S | Isolation of nucleic acid |
WO1996039813A1 (en) * | 1995-06-07 | 1996-12-19 | Flinders Technologies Pty. Ltd. | Dry solid medium for storage and analysis of genetic material |
US5595879A (en) * | 1991-08-08 | 1997-01-21 | Arizona Board Of Regents For And On Behalf Of The University Of Arizona | Multi-domain DNA ligands for protein and nucleic acid affinity chromatography and processing of solid-phase DNA |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5599667A (en) * | 1987-03-02 | 1997-02-04 | Gen-Probe Incorporated | Polycationic supports and nucleic acid purification separation and hybridization |
US5807527A (en) * | 1991-05-29 | 1998-09-15 | Flinders Technologies Pty. Ltd. | Solid medium and method for DNA storage |
US5496562A (en) * | 1988-10-05 | 1996-03-05 | Flinders Technologies Pty Ltd | Solid medium and method for DNA storage |
NL8900725A (nl) * | 1989-03-23 | 1990-10-16 | Az Univ Amsterdam | Werkwijze en combinatie van middelen voor het isoleren van nucleinezuur. |
US5234809A (en) * | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
GB9314249D0 (en) * | 1993-07-09 | 1993-08-18 | Proofname Ltd | Purification method and apparatus |
US5637687A (en) * | 1993-08-31 | 1997-06-10 | Wiggins; James C. | Methods and compositions for isolating nucleic acids |
DE69719409T2 (de) * | 1996-06-18 | 2004-01-15 | Rikagaku Kenkyusho | Verfahren zur Reinigung von DNS |
US5939264A (en) * | 1996-07-19 | 1999-08-17 | Iowa State University Research Foundation, Inc. | Genes and genetic markers for improved reproductive traits in animals |
GB9709728D0 (en) * | 1997-05-13 | 1997-07-02 | Dynal As | Single step method |
DE19746874A1 (de) * | 1997-10-23 | 1999-04-29 | Qiagen Gmbh | Verfahren zur Isolierung und Reinigung von Nukleinsäuren an hydrophoben Oberflächen - insbesondere unter Verwendung hydrophober Membranen |
-
1999
- 1999-09-10 DE DE69935232T patent/DE69935232T2/de not_active Expired - Lifetime
- 1999-09-10 AU AU58408/99A patent/AU764494B2/en not_active Ceased
- 1999-09-10 EP EP99945766A patent/EP1109899B1/de not_active Expired - Lifetime
- 1999-09-10 WO PCT/AU1999/000753 patent/WO2000015776A1/en active IP Right Grant
- 1999-09-10 CA CA002350315A patent/CA2350315C/en not_active Expired - Fee Related
- 1999-09-10 AT AT99945766T patent/ATE354651T1/de not_active IP Right Cessation
- 1999-09-10 US US09/394,008 patent/US6291179B1/en not_active Expired - Lifetime
- 1999-09-10 ES ES99945766T patent/ES2281971T3/es not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3872082A (en) * | 1971-05-19 | 1975-03-18 | Boehringer Mannheim Gmbh | Substituted purineribofuranoside-3,5-cyclophosphate compounds and process for their preparation |
US4533628A (en) * | 1983-08-03 | 1985-08-06 | New York University | Colony hybridization method |
WO1989000577A1 (en) * | 1987-07-22 | 1989-01-26 | Imperial Cancer Research Technology Ltd. | Digestion method |
US5595879A (en) * | 1991-08-08 | 1997-01-21 | Arizona Board Of Regents For And On Behalf Of The University Of Arizona | Multi-domain DNA ligands for protein and nucleic acid affinity chromatography and processing of solid-phase DNA |
WO1996018731A2 (en) * | 1994-12-12 | 1996-06-20 | Dynal A/S | Isolation of nucleic acid |
WO1996039813A1 (en) * | 1995-06-07 | 1996-12-19 | Flinders Technologies Pty. Ltd. | Dry solid medium for storage and analysis of genetic material |
Non-Patent Citations (5)
Title |
---|
"Qiagen Product Guide" 1996, QIAGEN GMBH * page 14 - page 16 * * |
SAMBROOK ET AL: "Molecular cloning (Laboratory Manual)" 1987, COLD SPRING HARBOUR PRESS , NEW YORK, US * page 9.38 - page 9.39 * * |
SAMBROOK J; FRITSCH E F; MANIATIS T: "Molecular cloning, plasmid vectors" 1989, COLD SPRING HARBOUR PRESS, NEW YORK, US , XP002286857 * page 1.25 - page 1.28 * * |
See also references of WO0015776A1 * |
STAMM S ET AL: "SOLID PHASE PCR" PCR. A PRACTICAL APPROACH, XX, XX, 1995, pages 55-70, XP000863765 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018206772A1 (de) | 2017-05-11 | 2018-11-15 | Immundiagnostik Ag | Verfahren und testbesteck zur quantitativen bestimmung von biomarkern in fäkalproben |
Also Published As
Publication number | Publication date |
---|---|
AU5840899A (en) | 2000-04-03 |
ATE354651T1 (de) | 2007-03-15 |
EP1109899A4 (de) | 2003-07-02 |
EP1109899B1 (de) | 2007-02-21 |
WO2000015776A1 (en) | 2000-03-23 |
CA2350315C (en) | 2008-12-23 |
US6291179B1 (en) | 2001-09-18 |
AU764494B2 (en) | 2003-08-21 |
DE69935232D1 (de) | 2007-04-05 |
ES2281971T3 (es) | 2007-10-01 |
CA2350315A1 (en) | 2000-03-23 |
DE69935232T2 (de) | 2008-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220170008A1 (en) | Polynucleotide capture materials, and systems using same | |
JP3943601B2 (ja) | アルカリプロテアーゼを用いる核酸の単離方法 | |
JP3787354B2 (ja) | 核酸の単離方法 | |
CA2586532C (en) | Compositions and methods for purifying nucleic acids from stabilization reagents | |
US20100173392A1 (en) | Room temperature elution of nucleic acids | |
US20070031880A1 (en) | Chemical treatment of biological samples for nucleic acid extraction and kits therefor | |
JP2002507121A (ja) | Rnaの単離方法 | |
KR20010080625A (ko) | 임의의 복잡한 출발물질로부터 핵산을 분리하기 위한배합물과 방법 그리고 복합한 유전자 분석법 | |
JP4435787B2 (ja) | タンパク質を変性させるための処方物および方法 | |
CA2725631A1 (en) | Method for isolating nucleic acids | |
US20140356860A1 (en) | Method for isolating nucleic acids from a veterinary whole blood sample | |
US20040126796A1 (en) | Extraction of DNA from biological samples | |
US6291179B1 (en) | Product and method for separation of a sample containing multiple sources of genetic material using a solid medium | |
CN103173432B (zh) | 分离核酸的方法及装置 | |
JP2007509620A (ja) | 迅速かつ低コストな核酸の単離方法 | |
JP2013523144A (ja) | 核酸の存在下で陰イオン界面活性剤イオンを沈殿させるための方法 | |
US11891599B2 (en) | Recovery of nucleic acids from solid supports | |
AU2016203610B2 (en) | Polynucleotide capture materials, and methods of using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010320 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030521 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: WHATMAN PLC |
|
17Q | First examination report despatched |
Effective date: 20031010 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070221 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070221 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070221 Ref country code: CH Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070221 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070221 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 69935232 Country of ref document: DE Date of ref document: 20070405 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: WHATMAN PLC |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070723 |
|
NLT2 | Nl: modifications (of names), taken from the european patent patent bulletin |
Owner name: WHATMAN PLC Effective date: 20070530 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2281971 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: CA |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
BECA | Be: change of holder's address |
Owner name: 27 GREAT WEST ROAD, BRENDFORD, MIDDLESEX TW8 9BW Effective date: 20070221 Owner name: *WHATMAN P.L.C. Effective date: 20070221 |
|
BECN | Be: change of holder's name |
Owner name: *WHATMAN P.L.C. Effective date: 20070221 |
|
26N | No opposition filed |
Effective date: 20071122 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070930 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070522 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070910 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070221 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070910 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20150928 Year of fee payment: 17 Ref country code: GB Payment date: 20150928 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20150928 Year of fee payment: 17 Ref country code: FR Payment date: 20150917 Year of fee payment: 17 Ref country code: SE Payment date: 20150929 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20150923 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20150929 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20150926 Year of fee payment: 17 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160930 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 69935232 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160911 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20161001 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20160910 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161001 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20170531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170401 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160930 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160910 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160910 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20160930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160911 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20181120 |